About Camitro
Camitro is a Healthcare company based in Menlo Park (United States) founded in 2018, and was acquired by ArQule in January 2001. Limited information available. Its chief executive, as recorded, is Barry Selick. Its focus areas include Diversified Pharmaceuticals.
Company details
Camitro was founded in 2018 and is headquartered in Menlo Park, United States. Leadership is provided by CEO Barry Selick. The companys domain, camitro.com, is registered, but details on industry, sector, operations, or services remain limited. No specific information on core activities or geographic scope beyond the headquarters location has been disclosed. Further data may be required for comprehensive analysis.
- Headquarters Menlo Park, United States
- Stage Acquired
- SectorsHealthcare
- Website camitro.com
- Acquired by ArQule (Jan 2001)
Investors in Camitro
Camitro has secured backing from 1 investor. Prominent investors backing the company include ArQule.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Cancer therapeutics are developed via a kinase inhibitor platform. | 1993 | arqule.com | Woburn, United States |
Investor details for Camitro
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Camitro
1 people are tracked at Camitro (1 in leadership).
| Name | Role | Group |
|---|---|---|
Barry Selick | CEO | Leadership |
Complete people profiles for Camitro
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Camitro
2 dated milestones of Camitro across 17 years, from founding to its latest funding, stage changes and deals.
- Exit Acquired by ArQule.
- Founded Camitro is founded.
Top companies in Pharmaceuticals & Distribution
3 companies that operate in the same segment as Camitro (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | USD 33.23 B | 28,000 | ||
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | USD 5.33 B | 55,000 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Camitro
Camitro was founded in 2018.
Camitro is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Barry Selick is the CEO of Camitro, as recorded in our data.
Camitro was founded in 2018 and is headquartered in Menlo Park, United States. Leadership is provided by CEO Barry Selick. The companys domain, camitro.com, is registered, but details on industry, sector, operations, or services remain limited. No specific information on core activities or geographic scope beyond the headquarters location has been disclosed. Further data may be required for comprehensive analysis.
Camitro has 1 investor. Key investors include ArQule.
Yes. Camitro was acquired by ArQule in January 2001.